Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration
In an environment where speed, equity, and scientific rigor are all imperative, modernizing patient recruitment is no longer a future goal. It is a present necessity.
Patient-Centricity is Reliant on Representative Clinical Studies
Recent FDA guidance aims to improve research inclusivity and the generalizability of clinical findings by ensuring diverse participant representation — it’s about better science, improved patient outcomes, and equitable healthcare access.
presented by
Rethinking The Entry Point to Healthcare in America: Collaboration in Communities
Healthcare in the U.S. today exists in a complex, fragmented and costly system, and the people this system is designed for deserve a holistic approach to best address their individual health needs.
Better Science, Better Medicine: How Clinical Research Advances Women’s Health
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented.
Navigating 2025: Three Key Trends Shaping the Future of Pharma
Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead.
Streamlined Participant Payments Unlock Clinical Trial Access for All
Participant payment options should include a variety of stipend and micropayment methods to meet participant preferences. Increasing the diversity of payment methods with both banked and unbanked options enhances flexibility, catering to a diverse and international participant base with varying payout needs.
Implementing Inclusivity: Putting Clinical Trial Equity Into Practice
In the realm of inclusivity and equity, planning early and engaging key stakeholders throughout the process makes it possible to make these changes while also safeguarding participants. How can researchers put clinical trial equity into practice?
presented by
How (and Where) to Find the Best Value Rehabilitation Programs for Brain Injuries
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one.
The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients
Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions.
To Continue the Momentum in Women’s Health, We Have No Time to Lose
We must look both “upstream” – at advocating for change on an institutional level – and “downstream” – at what we can do as individuals to help women secure the care they need.
Search, Click, Enroll? What Clinical Trials Can Learn from E-commerce
Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.
Five Strategies To Boost Clinical Trial Diversity
Without taking specific steps to improve trial diversity, advances in inclusive treatments will continue at a snail’s pace.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Alleviating Patient Burden in Clinical Trials: Modeling a Consumer-Grade Experience
By leveraging analytics to optimize the patient experience in clinical trials, patient attrition will decrease, improving clinical outcomes and research goals.
Atropos Health, Seqster Team Up to Reduce Disparities in Clinical Trials
Atropos Health and Seqster joined forces to address historical diversity and inclusion challenges in clinical trials. The partnership seeks to enable the swift creation of turnkey patient registries that generate real world evidence from existing registries in under 48 hours.
Health Equity Begins with Increasing Diversity in Clinical Research: AI Can Help
It’s critical that we address these examples of institutionalized bias and racism in how we approach clinical trials for drugs and devices. While it’s a daunting task, the path forward is surprisingly clear, and AI can be instrumental in the next step of overcoming unconscious biases inherent in clinical trial processes.
Inato Snags $20M to Make Clinical Trials More Diverse & Accessible
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they're interested.
How Patient Monitoring Is Poised to Revolutionize Healthcare
Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.